$TFX

TELEFLEX INC

Teleflex is a global medical technology company that designs, develops, manufactures and supplies primarily single-use devices for hospitals and healthcare providers. It sells products worldwide through its direct sales force, independent representatives and distributor networks. Its three reportable segments are Americas, EMEA, covering Europe, the Middle East and Africa, and Asia, covering Asia Pacific. Product categories include vascular and emergency medicine, interventional and surgical devices. Brands and products include Arrow catheters, EZ-IO access systems, QuikClot hemostatic products, GuideLiner and Turnpike catheters, the MANTA vascular closure device, and surgical products under brands such as Weck, MiniLap and Pilling. Teleflex also has Acute Care, Interventional Urology and OEM businesses. OEM designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company sells its products to hospitals, healthcare providers and distributors. Its major manufacturing operations are in the Czech Republic, Malaysia, Mexico and the United States. Teleflex is headquartered in Wayne, Pennsylvania.

AlphAI earnings readthird quarter 2026 · NOV 5Teleflex Reports Third Quarter Financial Results and Full Year 2026 OutlookVerdict: solid

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

0
1
0

No SEC Form 4 filings for $TFX in the last 30 days.

See all $TFX insider activity →
Low

Teleflex Earnings Call: EPS Raised Amid Transformation

Teleflex (TFX) reported Q3 revenue of $567.8M, up 0.2% GAAP and 3.0% constant-currency. Adjusted EPS rose 39.2% to $2.63, beating estimates. The company raised 2026 adjusted EPS guidance to $7.50-$7.75. Margins expanded, debt decreased, and share repurchases totaled $350M. Growth was driven by vascular and surgical businesses, while interventional revenue saw modest improvement. Integration challenges and tariff exposure remain.

Teleflex Invests US$5 Million in Chihuahua

Teleflex has opened a new machining shop in Chihuahua, investing US$5 million to expand high-precision medical device production. The 750 sqm facility adds to the company's four existing plants in the state, employing 2,000 people. Index Chihuahua praised the investment for boosting industrial competitiveness and medical device supply chains. Teleflex is a US-based multinational specializing in medical technologies.

TFX sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning TFX (TELEFLEX INC). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent TFX coverage spans earnings and financial news.

What's driving TFX

  • No new material information; the article recaps previously released earnings and guidance.

    tipranks.com · Nov 15, 2026

  • Teleflex has opened a new machining shop in Chihuahua, investing US$5 million to expand high-precision medical device production. The 750 sqm facility adds to the company's four existing plants in the state, employing 2,000 people. Index Chihuahua praised the investment for boosting industrial competitiveness and medical device supply chains. Teleflex is a US-based multinational specializing in medical technologies.

    mexico-now.com · Nov 13, 2026

  • Analyst upgrade suggests potential upside for Teleflex.

    tradingview.com · Nov 9, 2026

  • Earnings beat on margin but lack of forward guidance may limit upside.

    finance.yahoo.com · Nov 8, 2026

  • Guidance raise and buyback signal may support the stock.

    finance.yahoo.com · Nov 7, 2026

AlphAI scores every news story that mentions TFX with an AI model for sentiment and relevance, and aggregates insider trades from TELEFLEX INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $TFX

Score

Teleflex Earnings Call: EPS Raised Amid Transformation

Teleflex (TFX) reported Q3 revenue of $567.8M, up 0.2% GAAP and 3.0% constant-currency. Adjusted EPS rose 39.2% to $2.63, beating estimates. The company raised 2026 adjusted EPS guidance to $7.50-$7.75. Margins expanded, debt decreased, and share repurchases totaled $350M. Growth was driven by vascular and surgical businesses, while interventional revenue saw modest improvement. Integration challenges and tariff exposure remain.

Teleflex Invests US$5 Million in Chihuahua

Teleflex has opened a new machining shop in Chihuahua, investing US$5 million to expand high-precision medical device production. The 750 sqm facility adds to the company's four existing plants in the state, employing 2,000 people. Index Chihuahua praised the investment for boosting industrial competitiveness and medical device supply chains. Teleflex is a US-based multinational specializing in medical technologies.

Teleflex Q3 Earnings Call Highlights

Teleflex (NYSE: TFX) reported Q3 earnings, highlighting progress in integrating Vascular Intervention, with revenue up 0.2% to $210.3M. Vascular and Surgical revenues grew 4.6% and 5.1% respectively. Adjusted gross margin increased to 66.8%, including a $16.5M tariff refund. The company expects 2026 adjusted operating margin of 20% and remains optimistic about earnings potential. Teleflex repurchased $350M in stock and paid off a $700M term loan.

Teleflex Incorporated Q3 2026 Earnings Call Summary

Teleflex Incorporated reported Q3 2026 earnings, highlighting a strategic shift to a Global Business Unit structure and positive growth in the Interventional segment. The company expects 2027 to show improved earnings and margins due to share buybacks, debt reduction, and new product innovations. A $16.5 million tariff refund boosted margins, and the company plans $1 billion in share repurchases and $800 million in debt reduction.

Related tickers